Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Bonnefont-Rousselot

Showing results (151-160 of 153) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 153 results.
Journal of Hepatology|May 21, 2014
Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemiaMathilde Di Filippo, Philippe Moulin, Pascal Roy, et al.
Epilepsia|February 16, 2026
Exploring pathways leading to drug-resistant epilepsy for patients with cryptogenic new onset refractory status epilepticusAurélie Hanin, Clémence Marois, Martin Guillemaud, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 26, 2025
Diagnostic Performance of LIVERFASt as a Non-invasive Liver Fibrosis Test: Data from Three Cohorts of Patients with Metabolic Dysfunction-associated Steatotic Liver DiseaseNaim Alkhouri, Parvez Mantry, Humberto C Gonzalez, et al.
Pageof 16

Showing results (151-160 of 153) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 153 results.
Journal of Hepatology|May 21, 2014
Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemiaMathilde Di Filippo, Philippe Moulin, Pascal Roy, et al.
Epilepsia|February 16, 2026
Exploring pathways leading to drug-resistant epilepsy for patients with cryptogenic new onset refractory status epilepticusAurélie Hanin, Clémence Marois, Martin Guillemaud, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 26, 2025
Diagnostic Performance of LIVERFASt as a Non-invasive Liver Fibrosis Test: Data from Three Cohorts of Patients with Metabolic Dysfunction-associated Steatotic Liver DiseaseNaim Alkhouri, Parvez Mantry, Humberto C Gonzalez, et al.
Pageof 16